Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.68 USD | -2.91% | -4.30% | -12.67% |
Chart calendar Catalyst Pharmaceuticals, Inc.
Upcoming events on Catalyst Pharmaceuticals, Inc.
Past events on Catalyst Pharmaceuticals, Inc.
2024-04-02 03:10 pm | Cantor Fitzgerald Muscular Dystrophy Symposium |
2024-03-12 01:35 pm | Barclays Global Healthcare Conference |
2024-03-02 | Muscular Dystrophy Association Clinical & Scientific Conference - Poster Number: M174 |
2024-02-29 08:30 am | Q4 2023 Earnings Call |
2024-02-28 06:03 pm | Q4 2023 Earnings Release |
2023-11-29 10:30 am | Piper Sandler Healthcare Conference |
2023-11-09 08:30 am | Q3 2023 Earnings Call |
2023-11-08 04:11 pm | Q3 2023 Earnings Release |
2023-09-26 11:05 am | Cantor Global Healthcare Conference |
2023-09-04 09:00 am | International Epilepsy Congress - Poster number: P373 |
2023-09-04 08:30 am | International Epilepsy Congress - Poster number: P149 |
2023-09-03 10:30 am | International Epilepsy Congress - Oral Presentation number: 370 |
2023-09-03 09:00 am | International Epilepsy Congress - Poster number: P048 |
2023-09-02 09:00 am | International Epilepsy Congress - Poster number: P367 |
2023-08-22 09:00 am | Annual General Meeting |
2023-08-10 08:30 am | Q2 2023 Earnings Call |
2023-08-09 04:17 pm | Q2 2023 Earnings Release |
2023-05-11 08:30 am | Q1 2023 Earnings Call |
2023-05-10 04:27 pm | Q1 2023 Earnings Release |
2023-03-16 08:30 am | Q4 2022 Earnings Call |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 102 101 1.15% | 119 118 0.84% | 141 141 0.09% | 214 214 -0.04% | 398 394 1.18% | 461 |
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 189 |
EBIT Million USD | Released Forecast Spread | 31,8 35,0 -9.09% | 41,3 43,1 -4.22% | 52,4 55,2 -5.06% | 102 101 1.15% | 86,8 74,2 17.03% | 179 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 33,4 36,6 -8.7% | 41,9 43,8 -4.4% | 52,7 55,6 -5.35% | 105 102 2.5% | 94,5 84,9 11.38% | 188 |
Net income Million USD | Released Forecast Spread | 31,9 34,8 -8.45% | 75,0 73,0 2.68% | 39,5 42,6 -7.42% | 83,1 68,8 20.71% | 71,4 67,0 6.61% | 137 |
EPS USD | Released Forecast Spread | 0,30 0,33 -9.09% | 0,71 0,69 2.9% | 0,37 0,40 -7.04% | 0,75 0,73 2.18% | 0,63 0,59 6.33% | 1,13 |
Announcement Date | 16/03/20 | 15/03/21 | 16/03/22 | 15/03/23 | 28/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 38,3 38,2 0.33% | 43,1 42,8 0.78% | 53,1 49,1 8.23% | 57,2 53,7 6.61% | 60,8 60,6 0.19% | 85,4 81,6 4.59% | 99,6 91,7 8.59% | 103 100 2.31% | 111 106 4.39% | 98,8 | 112 | 121 | 129 | 125 |
EBITDA Million USD | Released Forecast Spread | 49,8 | 60,8 | 56,1 | 54,4 | ||||||||||
EBIT Million USD | Released Forecast Spread | 12,7 15,5 -17.98% | 17,4 18,9 -8.25% | 28,6 24,1 18.39% | 29,2 27,0 7.98% | 30,8 29,6 4.16% | 35,6 47,8 -25.45% | 46,7 36,6 27.68% | -37,2 -20,9 -77.57% | 41,7 36,3 14.78% | 32,6 | 44,5 | 49,6 | 52,5 | 47,6 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 12,8 15,8 -18.86% | 17,5 19,1 -8.79% | 28,2 24,3 16.29% | 26,0 27,2 -4.32% | 33,0 30,4 8.67% | 37,3 47,8 -21.86% | 48,5 37,9 27.9% | -38,0 -19,2 -97.82% | 46,7 37,0 26.1% | 37,0 | 46,7 | 51,2 | 53,6 | 49,9 |
Net income Million USD | Released Forecast Spread | 9,31 12,5 -25.37% | 13,2 14,7 -10.07% | 21,6 18,2 18.83% | 22,7 20,5 11.23% | 25,5 19,9 27.87% | 29,6 36,5 -18.99% | 37,8 29,0 30.11% | -30,8 -20,0 -53.59% | 34,8 30,4 14.58% | 26,1 | 34,4 | 37,9 | 38,5 | 37,4 |
EPS USD | Released Forecast Spread | 0,09 0,12 -22.41% | 0,12 0,14 -11.76% | 0,20 0,17 17.65% | 0,20 0,19 5.26% | 0,22 0,21 3.77% | 0,26 0,32 -19.25% | 0,33 0,25 29.92% | -0,29 -0,19 -52.63% | 0,29 0,27 9.43% | 0,21 | 0,28 | 0,31 | 0,32 | 0,28 |
Announcement Date | 16/03/22 | 10/05/22 | 09/08/22 | 09/11/22 | 15/03/23 | 10/05/23 | 09/08/23 | 08/11/23 | 28/02/24 | - | - | - | - | - |
Past sector events for Catalyst Pharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CPRX Stock
- Calendar Catalyst Pharmaceuticals, Inc.